| ［1］ |
Wang TL, Zhou C, Shen YW, et al. Prevalence of androgenetic alopecia in China: a community⁃based study in six cities［J］. Br J Dermatol, 2010,162（4）:843⁃847. doi: 10.1111/j.1365⁃2133. 2010.09640.x.
|
| ［2］ |
中国医师协会美容与整形医师分会毛发整形美容专业委员会. 中国人雄激素性脱发诊疗指南［J］. 中国美容整形外科杂志, 2019,30（1）:6. doi: 10.3969/j.issn.1673⁃7040.2019.01.001.
|
| ［3］ |
Kobielak K, Pasolli HA, Alonso L, et al. Defining BMP functions in the hair follicle by conditional ablation of BMP receptor IA［J］. J Cell Biol, 2003,163（3）:609⁃623. doi: 10.1083/jcb.2003 09042.
|
| ［4］ |
Higgins CA, Chen JC, Cerise JE, et al. Microenvironmental reprogramming by three⁃dimensional culture enables dermal papilla cells to induce de novo human hair⁃follicle growth［J］. Proc Natl Acad Sci U S A, 2013,110（49）:19679⁃19688. doi: 10.1073/pnas.1309970110.
|
| ［5］ |
Ceruti JM, Oppenheimer FM, Leirós GJ, et al. Androgens downregulate BMP2 impairing the inductive role of dermal papilla cells on hair follicle stem cells differentiation［J］. Mol Cell Endocrinol, 2021,520:111096. doi: 10.1016/j.mce.2020. 111096.
|
| ［6］ |
Belgardt E, Steinberg T, Husari A, et al. Force⁃responsive Zyxin modulation in periodontal ligament cells is regulated by YAP rather than TAZ［J］. Cell Signal, 2020,72:109662. doi: 10.1016/j.cellsig.2020.109662.
|
| ［7］ |
Wang Y, Gilmore TD. Zyxin and paxillin proteins: focal adhesion plaque LIM domain proteins go nuclear［J］. Biochim Biophys Acta, 2003,1593（2⁃3）:115⁃120. doi: 10.1016/s0167⁃4889（02）00349⁃x.
|
| ［8］ |
Liu Q, Shi X, Zhang Y, et al. Increased expression of Zyxin and its potential function in androgenetic alopecia［J］. Front Cell Dev Biol, 2020,8:582282. doi: 10.3389/fcell.2020.582282.
|
| ［9］ |
Seleit I, Bakry OA, Badr E, et al. Vitamin D receptor gene polymorphisms Taq⁃1 and Cdx⁃1 in female pattern hair loss［J］. Indian J Dermatol, 2020,65（4）:259⁃264. doi: 10.4103/ijd.IJD_482_18.
|
| ［10］ |
Hu S, Li Z, Lutz H, et al. Dermal exosomes containing miR⁃218⁃5p promote hair regeneration by regulating β⁃catenin signaling［J］. Sci Adv, 2020,6（30）:eaba1685. doi: 10.1126/sciadv.aba1685.
|
| ［11］ |
Deng W, Hu T, Han L, et al. miRNA microarray profiling in patients with androgenic alopecia and the effects of miR⁃133b on hair growth［J］. Exp Mol Pathol, 2021,118:104589. doi: 10.1016/j.yexmp.2020.104589.
|
| ［12］ |
Rakowska A, Slowinska M, Kowalska⁃Oledzka E, et al. Dermoscopy in female androgenic alopecia: method standardization and diagnostic criteria. Int J Trichology, 2009,1（2）:123⁃30. doi: 10.4103/0974⁃7753.58555.
|
| ［13］ |
Lee WS, Ro BI, Hong SP, et al. A new classification of pattern hair loss that is universal for men and women: basic and specific （BASP） classification［J］. J Am Acad Dermatol, 2007,57（1）:37⁃46. doi: 10.1016/j.jaad.2006.12.029.
|
| ［14］ |
Chung Y, Lee SH, Choi SK. Fundamental basis of scalp layering techniques to protect against wound infection: a comparative study between conventional and in⁃to⁃out dissection of the superficial temporal artery［J］. World Neurosurg, 2017,97:304⁃311. doi: 10.1016/j.wneu.2016.10.002.
|
| ［15］ |
Soga S, Koyama T, Mikoshi A, et al. MR imaging of hair and scalp for the evaluation of androgenetic alopecia［J］. Magn Reson Med Sci, 2021,20（2）:160⁃165. doi: 10.2463/mrms.mp. 2020⁃0026.
|
| ［16］ |
Kerkemeyer KL, de Carvalho LT, Jerjen R, et al. Female pattern hair loss in men: a distinct clinical variant of androgenetic alopecia［J］. J Am Acad Dermatol, 2020,S0190⁃9622（20）32632⁃3. doi: 10.1016/j.jaad.2020.09.042.
|
| ［17］ |
Banihashemi M, Nahidi Y, Meibodi NT, et al. Serum vitamin D3 level in patients with female pattern hair loss［J］. Int J Trichology, 2016,8（3）:116⁃120. doi: 10.4103/0974⁃7753.188965.
|
| ［18］ |
York K, Meah N, Bhoyrul B, et al. A review of the treatment of male pattern hair loss［J］. Expert Opin Pharmacother, 2020,21（5）:603⁃612. doi: 10.1080/14656566.2020.1721463.
|
| ［19］ |
Nguyen D⁃D, Marchese M, Cone EB, et al. Investigation of suicidality and psychological adverse events in patients treated with finasteride［J］. JAMA Dermatol. 2021,157（1）:35⁃42. doi: 10.1001/jamadermatol.2020.3385.
|
| ［20］ |
Jimenez⁃Cauhe J, Saceda⁃Corralo D, Rodrigues⁃Barata R, et al. Characterization and management of hypertrichosis induced by low⁃dose oral minoxidil in the treatment of hair loss［J］. J Am Acad Dermatol, 2021,84（1）:222⁃223. doi: 10.1016/j.jaad.2020. 08.124.
|
| ［21］ |
Randolph M, Tosti A. Oral minoxidil treatment for hair loss: a review of efficacy and safety［J］. J Am Acad Dermatol, 2021,84（3）:737⁃746. doi: 10.1016/j.jaad.2020.06.1009.
|
| ［22］ |
Rodrigues⁃Barata R, Moreno⁃Arrones OM, Saceda⁃Corralo D, et al. Low⁃dose oral minoxidil for female pattern hair loss: a unicenter descriptive study of 148 women［J］. Skin Appendage Disord, 2020,6（3）:175⁃176. doi: 10.1159/000505820.
|
| ［23］ |
Dubin DP, Lin MJ, Leight HM, et al. The effect of platelet⁃rich plasma on female androgenetic alopecia: a randomized controlled trial［J］. J Am Acad Dermatol, 2020,83（5）:1294⁃1297. doi: 10. 1016/j.jaad.2020.06.1021.
|
| ［24］ |
Shapiro J, Ho A, Sukhdeo K, et al. Evaluation of platelet⁃rich plasma as a treatment for androgenetic alopecia: a randomized controlled trial［J］. J Am Acad Dermatol, 2020,83（5）:1298⁃1303. doi: 10.1016/j.jaad.2020.07.006.
|
| ［25］ |
Zhou Y, Yu S, Zhao J, et al. Effectiveness and safety of botulinum toxin type A in the treatment of androgenetic alopecia［J］. Biomed Res Int, 2020,2020:1501893. doi: 10.1155/2020/1501893.
|
| ［26］ |
Shin H, Won CH, Chung WK, et al. Up⁃to⁃date clinical trials of hair regeneration using conditioned media of adipose⁃derived stem cells in male and female pattern hair loss［J］. Curr Stem Cell Res Ther, 2017,12（7）:524⁃530. doi: 10.2174/1574888X126 66170504120244.
|
| ［27］ |
Tak YJ, Lee SY, Cho AR, et al. A randomized, double⁃blind, vehicle⁃controlled clinical study of hair regeneration using adipose⁃derived stem cell constituent extract in androgenetic alopecia［J］. Stem Cells Transl Med, 2020,9（8）:839⁃849. doi: 10.1002/sctm.19⁃0410.
|
| ［28］ |
Uzel B, Takano G, Chartuni J, et al. Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: a randomized, placebo⁃controlled trial［J］. Dermatol Ther, 2021,34（1）:e14622. doi: 10.1111/dth.14622.
|
| ［29］ |
Kutlu Ö. Dexpanthenol may be a novel treatment for male androgenetic alopecia: analysis of nine cases［J］. Dermatol Ther, 2020,33（3）:e13381. doi: 10.1111/dth.13381.
|
| ［30］ |
Kutlu Ö, Metin A. Systemic dexpanthenol as a novel treatment for female pattern hair loss［J］. J Cosmet Dermatol, 2021,20（4）:1325⁃1330. doi: 10.1111/jocd.13729.
|
| ［31］ |
Ismail FF, Meah N, Trindade de Carvalho L, et al. Safety of oral bicalutamide in female pattern hair loss: a retrospective review of 316 patients［J］. 2020,83（5）:1478⁃1479. doi: 10.1016/j.jaad.2020.03.034.
|
| ［32］ |
Exicure and allergan enter into collaboration, option and license agreement to discover and develop sna⁃based treatments for hair loss disorders［EB/OL］. https://www.businesswire.com/news/home/ 20191114005106/en/Exicure⁃Allergan⁃Enter⁃Collaboration⁃Option⁃License⁃Agreement.
|
| ［33］ |
Lee J, Bӧscke R, Tang PC, et al. Hair follicle development in mouse pluripotent stem cell⁃derived skin organoids［J］. Cell Rep, 2018,22（1）:242⁃254. doi: 10.1016/j.celrep.2017.12.007.
|
| ［34］ |
Lee J, Rabbani CC, Gao H, et al. Hair⁃bearing human skin generated entirely from pluripotent stem cells［J］. Nature, 2020,582（7812）:399⁃404. doi: 10.1038/s41586⁃020⁃2352⁃3.
|
